Chang Kyun Han

Title: Innovations of Chang Kyun Han

Introduction

Chang Kyun Han is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific enzyme activities. His work has implications for treating various metabolic disorders.

Latest Patents

Chang Kyun Han holds a patent for a compound that inhibits the 11Beta-HSD1 enzyme. The patent describes a novel compound or a pharmaceutically acceptable salt that selectively inhibits the activity of 11β-HSD1 (11β-Hydroxysteroid dehydrogenase type 1). This compound can be effectively used as a therapeutic agent for conditions such as non-insulin dependent type II diabetes, insulin resistance, obesity, lipid disorder, and metabolic syndrome. The patent also includes a method for producing the compound and a pharmaceutical composition containing it as an active ingredient.

Career Highlights

Throughout his career, Chang Kyun Han has worked with various pharmaceutical companies, including Ahn-gook Pharmaceutical Co., Ltd. and Bamichem Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Chang Kyun Han has collaborated with notable colleagues, including Soon Kil Ahn and Jin Auh. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Chang Kyun Han's innovative work in developing compounds that inhibit specific enzyme activities showcases his significant contributions to medical science. His patent reflects a promising avenue for treating metabolic disorders, highlighting the importance of his research in the pharmaceutical industry.